CTSD and Alzheimer disease: Moreover, considering the implication of plasma components such as cholesterol, thrombin, and cytokines in AD [56,57,58,59], further correlation analysis of plasma cathepsin D with AD-related factors could help improve the performance of our AD biomarker model.